These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10624)

  • 1. Structural studies on des-pentapeptide (B26-30)-insulin. V. High resolution NMR studies.
    Sci Sin; 1976; 19(4):497-504. PubMed ID: 10624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies on des-pentapeptide (B26-30)-insulin. III. State of aggregation, tyrosyl environment, and peptide backbone conformation in solution.
    Sci Sin; 1976; 19(4):475-85. PubMed ID: 10622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies on des-pentapeptide (B26-30)-insulin. IV. A preliminary investigation on the hydrophobic region by employing a fluorescence probe, 1-p-toluidinylnaphthalene-8-sulphonate.
    Sci Sin; 1976; 19(4):486-96. PubMed ID: 10623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies on des-pentapeptide (B26-30)-insulin. I. The preparation and properties of des-pentapeptide-insulin.
    Sci Sin; 1976; 19(3):351-7. PubMed ID: 788152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H spin system identifications of S-sulfonated insulin B chain with 2D-NMR.
    Hua QX
    Sci China B; 1989 Aug; 32(8):948-59. PubMed ID: 2692597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
    Jørgensen AM; Olsen HB; Balschmidt P; Led JJ
    J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of an engineered insulin monomer at neutral pH.
    Olsen HB; Ludvigsen S; Kaarsholm NC
    Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue.
    Kurapkat G; Siedentop M; Gattner HG; Hagelstein M; Brandenburg D; Grötzinger J; Wollmer A
    Protein Sci; 1999 Mar; 8(3):499-508. PubMed ID: 10091652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-chain shortening of matrix-bound insulin by pepsin, I:Preparation and properties of bovine des-pentapeptide(B26-30) insulin (suthor's transl)].
    Gattner HG
    Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1397-404. PubMed ID: 240771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I (IGF-I): solution properties and NMR chemical shift assignments near physiological pH.
    Kuang Z; Yao S; McNeil KA; Forbes BE; Wallace JC; Norton RS
    Growth Horm IGF Res; 2009 Jun; 19(3):226-31. PubMed ID: 19056307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobility of the N-terminal segment of rabbit skeletal muscle F-actin detected by 1H and 19F nuclear magnetic resonance spectroscopy.
    Heintz D; Kany H; Kalbitzer HR
    Biochemistry; 1996 Oct; 35(39):12686-93. PubMed ID: 8841112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation.
    Whittingham JL; Scott DJ; Chance K; Wilson A; Finch J; Brange J; Guy Dodson G
    J Mol Biol; 2002 Apr; 318(2):479-90. PubMed ID: 12051853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high resolution solution structure of the insulin monomer determined by NMR.
    Kaarsholm NC; Ludvigsen S
    Receptor; 1995; 5(1):1-8. PubMed ID: 7613479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin.
    Reymond MT; Huo S; Duggan B; Wright PE; Dyson HJ
    Biochemistry; 1997 Apr; 36(17):5234-44. PubMed ID: 9136885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sample pH on the conformational backbone dynamics of a pseudotripeptide (H-Tyr-Tic psi [CH2-NH]Phe-OH) incorporating a reduced peptide bond: an NMR investigation.
    Carpenter KA; Wilkes BC; Schiller PW
    Biopolymers; 1995 Dec; 36(6):735-49. PubMed ID: 8555421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational change and inactivation of membrane phospholipid-related activity of cardiotoxin V from Taiwan cobra venom at acidic pH.
    Chiang CM; Chien KY; Lin HJ; Lin JF; Yeh HC; Ho PL; Wu WG
    Biochemistry; 1996 Jul; 35(28):9167-76. PubMed ID: 8703922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
    Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and dynamics of a protein assembly. 1H-NMR studies of the 36 kDa R6 insulin hexamer.
    Jacoby E; Hua QX; Stern AS; Frank BH; Weiss MA
    J Mol Biol; 1996 Apr; 258(1):136-57. PubMed ID: 8613983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conformational manifold of ferricytochrome c explored by visible and far-UV electronic circular dichroism spectroscopy.
    Hagarman A; Duitch L; Schweitzer-Stenner R
    Biochemistry; 2008 Sep; 47(36):9667-77. PubMed ID: 18702508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The solution conformation of tubulin-beta(422-434)-NH2 and its Nac-DATADEQG-NH2 fragment based on NMR.
    Otter A; Scott PG; Maccioni RB; Kotovych G
    Biopolymers; 1991 Mar; 31(4):449-58. PubMed ID: 1863694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.